Session Information
Clinical Nutrition Week 12
Click here to go to the previous page
Clostridium Difficile: An Organism with a New Virulence
Track
:
Gut Microbiota
Program Code:
T32
Date:
Tuesday, January 24, 2012
Time:
1:00 PM to 2:30 PM
EST
Location:
Northern Hemisphere Salon D + Corridor
COORDINATOR
:
Beth Krzywda
MODERATOR
:
Deborah Andris
PRESENTER
(S):
Charles Edmiston, Jr, PhD
Todd Canada, PharmD, BCNSP, FASHP
Heidi Bahna, MD
PRESENTER/MODERATOR
(S):
Charles Edmiston, Jr, PhD
Todd Canada, PharmD, BCNSP, FASHP
Deborah Andris
Heidi Bahna, MD
SUBMITTER
:
Beth Krzywda
Description
1. Summarize the etiology and pathogenesis of C. Difficile infections
2. Distinguish among selective pharmaceutical agents that predispose patients to C. Difficile colitis
3. Define the unique risk factors for patients with inflammatory bowel disease and C. Difficile infections and their treatment challenges
2. Distinguish among selective pharmaceutical agents that predispose patients to C. Difficile colitis
3. Define the unique risk factors for patients with inflammatory bowel disease and C. Difficile infections and their treatment challenges
Handout Online
(Code: T32)
This session is a part of:
This session is a part of:
